Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Immunocore Holdings (IMCR) has provided an update.
Immunocore Holdings plc appointed Mr. Ranjeev Krishana, a seasoned executive with a history at Baker Bros. Advisors and Pfizer, to its Board of Directors on May 28, 2024. Krishana brings extensive pharmaceutical and international market experience to the role and will serve until the 2025 annual shareholder meeting. Concurrent with his appointment, the company entered into a Registration Rights Agreement with the BBA Funds, granting them rights for resale registration of certain company securities. This agreement entails the company’s commitment to file necessary registration statements upon request and allows the BBA Funds limited opportunities for underwritten offerings to sell their shares, with the company covering related expenses and providing indemnification.
Learn more about IMCR stock on TipRanks’ Stock Analysis page.
